Industry reports
Editor highlights

Free Market Research Guides to Download

Generic Drug Analysis & Statistics in Europe Countries, January 2013 (p2)

» Purchase Premium Reports

31-80 of 71 reports
ratiopharm GmbH SWOT Analysis, Strategy, Revenues and Profits

ratiopharm GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • February 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Germany
The Pharmaceutical Market: Russia, Business Monitor International

The Pharmaceutical Market: Russia, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN RUSSIA The Russian pharmaceutical market remains a powerhouse in the Emerging Europe ...

  • Industries : Generic Drug
  • Countries : Russian Federation
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence ...

  • Industries : Generic Drug
  • Countries : Europe, United States, World, Japan, Spain, Italy, France, Germany
Italy Pharmaceutical Market Overview - Challenging outlook due to austerity and falling birth rate

Italy Pharmaceutical Market Overview - Challenging outlook due to austerity and falling birth rate

  • $ 5 700
  • Industry report
  • December 2012
  • by Datamonitor

High national debt and a falling birth rate create a poor economic outlook and challenging market environment for pharma companies in Italy. Generic penetration is among the lowest in the world. However, ...

  • Industries : Generic Drug
  • Countries : Italy
Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • November 2012
  • by ICD Research

Synopsis ICD Research's "Apotex, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Generic Drug
  • Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom
Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • November 2012
  • by Industry Experts

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, United Kingdom, Germany, France, Spain, Italy, India, South Korea
Key Findings: Spain Pharmaceutical Market Overview

Key Findings: Spain Pharmaceutical Market Overview

  • $ 1 910
  • Industry report
  • October 2012
  • by SCRIP Insights

The market environment in Spain is extremely challenging, with cost containment measures introduced in 2010-12 contributing to an overall reduction in pharmaceutical spending. The changes are multi-pronged ...

  • Industries : Generic Drug
  • Countries : Spain
Spain Pharmaceutical Market Overview - Continued stagnation as generics and price cuts erode market value

Spain Pharmaceutical Market Overview - Continued stagnation as generics and price cuts erode market value

  • $ 5 700
  • Industry report
  • October 2012
  • by Datamonitor

The market environment in Spain is extremely challenging, with cost containment measures introduced in 2010-12 contributing to an overall reduction in pharmaceutical spending. The changes are multi-pronged ...

  • Industries : Generic Drug
  • Countries : Spain
Portugal Pharmaceuticals and Healthcare Q4 2012

Portugal Pharmaceuticals and Healthcare Q4 2012

  • $ 1 300
  • Industry report
  • September 2012
  • by Business Monitor International

Includes 3 FREE quarterly updates. BMI View: Portugal continues to implement widespread changes to its healthcare sector as part of the EU/IMF/ECB's EUR78bn economic rescue package approved in May 2011, ...

  • Industries : Generic Drug
  • Countries : Portugal
Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • August 2012
  • by MarketLine

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Sandoz International GmbH SWOT

Sandoz International GmbH SWOT

  • $ 175
  • Company report
  • June 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Sandoz, the generic business division of Novartis, ...

  • Industries : Generic Drug
  • Countries : Germany
Global Biosimilars Industry

Global Biosimilars Industry

  • $ 4 500
  • Industry report
  • April 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. Annual estimates and forecasts are provided fo ...

  • Industries : Generic Drug
  • Countries : World, India, Europe, United States, Japan, France, Germany, Asia, United Kingdom, North America
Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Generic Drug
  • Countries : Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom
Gauging the Biosimilar Effect: will  the market boom or bust?

Gauging the Biosimilar Effect: will the market boom or bust?

  • $ 895
  • Industry report
  • January 2012
  • by Firstword Pharma

It was supposed to be the ?epoch of biosimilars?, or drugs that copied existing biologics but had the potential to be more cost-effective. Yet five years later, biosimilars have failed to reach thei ...

  • Industries : Generic Drug
  • Countries : Germany, United States
Mylan - Strategic SWOT Analysis Review

Mylan - Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • December 2011
  • by Global Data

Mylan, formerly known as Generics (UK) Ltd, is a supplier of generic pharmaceuticals, encompassing all the major therapeutic classes. With over 350 products in its portfolio, the company supplies ove ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Emerging Pharmaceutical Markets Globally

Emerging Pharmaceutical Markets Globally

  • $ 1 400
  • Industry report
  • November 2011
  • by RNCOS

The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies ...

  • Industries : Generic Drug
  • Countries : Indonesia, India, Brazil, China, Mexico, Russian Federation, World, Asia, South America
Mylan SWOT Analysis, Strategy, Revenues and Profits

Mylan SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : United Kingdom
UK Generics Market Analysis

UK Generics Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years. Besides, due to the increasing consumer spending on the branded ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Mylan (formerly Generics (UK) Limited)-Detailed Product Pipeline

Mylan (formerly Generics (UK) Limited)-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Mylan (formerly Generics (UK) Limited)-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report

Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report

  • $ 350
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Gedeon Richter Generics Company Intelligence Report

Gedeon Richter Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary
ratiopharm Generics Company Intelligence Report

ratiopharm Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom
Stada Arzneimittel Generics Company Intelligence Report

Stada Arzneimittel Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany
Krka Generics Company Intelligence Report

Krka Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Europe, Slovenia, Germany, World, China
Ranbaxy Generics Company Intelligence Report

Ranbaxy Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : South Africa, Canada, India, World, Africa, United States, Romania, Japan, Mexico, Malaysia, China, North America, Asia, Europe
Sanofi-Aventis Generics Company Intelligence Report

Sanofi-Aventis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Czech Republic, United Kingdom, Europe, Brazil, France, Germany, South America, World, Mexico, Slovakia (slovak Republic), Romania, Portugal
Actavis Generics Company Intelligence Report

Actavis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America
Egis Generics Company Intelligence Report

Egis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary, Europe, Russian Federation, France, Austria, South Korea, World
Generic Drug in Australia: Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry

Generic Drug in Australia: Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry

  • $ 15 200
  • Industry report
  • December 2010
  • by Datamonitor

About This Report Pharma is facing slowing sales growth in the developed pharmaceutical industries, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means ...

  • Industries : Generic Drug
  • Countries : Australia, Spain, Italy, France, Germany, Japan, Russian Federation, Europe, China, World, United States, United Kingdom, Oceania, Asia
France Pharmaceutical Industry Overview ? - Austerity measures will impact pharmaceutical industry growth

France Pharmaceutical Industry Overview ? - Austerity measures will impact pharmaceutical industry growth

  • $ 11 400
  • Industry report
  • December 2010
  • by Datamonitor

About This Report The prescription pharma industry in France was valued at USD 38.8bn in sales in 2009, having by 3.1% (CAGR; 2005'09). Key growth drivers include growing use of chronic high-value innovative ...

  • Industries : Generic Drug
  • Countries : France

» View Public Reports

78 reports

The European Generic Drug : Sector Statistics

  • Industry report
  • November 2013
  • 31 pages

... The generic medicines market grow 16 increase savings for the bulgarian health system making the generic medicines market grow 17 external reference pricing not for generics key risks when introducing erp ...


» Read our Company Profiles

1 Companies

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.